Skip to content

Comparison of Different Treatment Methods for Gait Rehabilitation of Sub-Acute Post Stroke Patients With Dropped Foot

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01876030
Enrollment
40
Registered
2013-06-12
Start date
2013-06-30
Completion date
Unknown
Last updated
2016-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dropped Foot

Keywords

Functional electrical stimulation (FES), Sub acute stroke, Gait analysis

Brief summary

The investigators hypothesize that the gait pattern of following the utilization of a functional electrical stimulation device will be much improved when compared to the effect of regular gait re-education with ankle-foot-orthosis (AFO) fitting in patients in early stages following stroke.

Interventions

DEVICEFES

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sub-acute stroke patients suffering a first stroke with clinical presentation, according to the WHO definitions * Patients suffering from unilateral foot drop * Independent ambulation before the stroke * Cognitive and cooperative ability to follow simple instructions * Neurological condition severity mild to moderate (between 3 and 15, according to the National Institutes of Health Stroke Scale; NIHSS). * Ability to walk with or without a walking aid (cane, walker), with or without assistance. Functional Ambulation Classification (FAC) of at least 2 * Independently capable to understand an informed consent form.

Exclusion criteria

* Cognitive disorders preventing the subject from understanding the trial protocol or following the researcher's instructions * Orthopaedic injury to the paretic or non-paretic limbs * Motor disability due to neurological diagnosis, e.g. multiple sclerosis, cerebral palsy, spinal cord injury, and Parkinson * Peripheral injury of the peroneal nerve or sciatic nerve * Pregnant or nursing females

Design outcomes

Primary

MeasureTime frameDescription
Change in velocity of gaitBaseline, 4 weeks and 12 week follwing baselineMeasured in m/s and the change will be in %
Change in step lengthBaseline, 4 and 12 weeks following baselineMeasured in cm and the change will be in %

Secondary

MeasureTime frameDescription
Gait symmetryBaseline, 4 and 12 weeks following baselineCalculated symmetry of stance duration, swing duration, double support duration, step length, base width, and foot progression
Muscle activity patternsBaseline, 4 and 12 weeks following baselineSurface electromyography (EMG) electrodes will be attached to 6 muscles for evaluation of dynamic muscle activation pattern during gait without the intervention. Specifically, we will monitor the medial gastrocnemius, soleus and tibialis anterior, bilaterally.
Functional assessmentAt baseline, 4 and 12 weeks following baselineSelective motor control during dorsiflexion will be tested with and without flexed knee according to the classification of three levels: normal, impaired, and unable. This test will be utilized for matching of the test group and control group. Physical evaluation will be conducted to assess the muscle tonus of the gastrocnemius, tibialis anterior and quadriceps according to Ashwart scale. Passive joint range of motion will also be assessed. Functional evaluation of each subject will be accomplished using the 10-meter walk. The Functional Ambulation Classification (FAC) will also be applied in order to obtain a patient prognosis level with regard to ambulation. Time up and Go (TUG) test will be performed in the in gait laboratory so that the performance of the subjects during the trials can be videotaped.

Countries

Israel

Contacts

Primary ContactSigal Portnoy, PhD
sigalp@hadassah.org.il0097225844492
Backup ContactHadas Lemberg, PhD
lhadas@hadassah.org.il00 972 2 6777572

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026